TSHA - Taysha Gene Therapies Stock Soars On FY23 Results: Here's Why | Benzinga
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) shares are climbing after the company reported its fiscal year 2023 results after the bell Tuesday. Here's a look at the highlights.
The Details: The company reported fiscal year 2023 losses of 96 cents per share, compared to losses of $3.78 per share from the prior year. Taysha reported it had $143.9 million in cash and cash equivalents on Dec. 31, 2023.
The company also provided clinical updates including the completed dosing in cohort one of its REVEAL Phase 1/2 adolescent ...